TitleIssue datePagesPrice[¥]StatusRemark
Market Athorization Procedure for Regenerative Medicine [RM001]N/A1515,000
Technical Guidance for Quality, Non-Clinical Studies and Clinical Studies of Regenerative Medicine Products (Human Cell Processed Products) [RM002]6/27/20162323,000
Checkpoint for Efficiant Regulatory Strategy Meeting for Regenerative Medicine Products: Quality [RM003]3/8/20131010,000
Checkpoint for Efficiant Regulatory Strategy Meeting for Regenerative Medicine Products: Sterility test and myocoplasma test [RM004]1/17/201422,000
Checkpoint for Efficiant Regulatory Strategy Meeting for Regenerative Medicine Products: Non-clincal safety [RM005]3/8/201333,000
Key Points for the Submission of Initial Clinical Trial Notification of Regenerative Medicine Product  (Powerpoint) [RM006]N/A44,000